An experimental drug for severe COVID-19 cuts the risk of hospitalisation or death by about half, interim clinical trial results suggest.The Australian government has ordered 300,000 doses of a new antiviral pill that has shown signs of slashing COVID-19 deaths and hospitalisations by around 50 per cent.
Molnupiravir has been developed as a first-line treatment for adult coronavirus patients with mild to moderate symptoms. Meanwhile, Australia has received 15,000 additional doses of the antibody treatment sotrovimab, which is used to stop the virus replicating.The national stockpile of the drug, administered by intravenous infusion within five days of patients developing symptoms, is expected to exceed 30,000 doses this year.
"Even with 100 per cent of the population fully vaccinated, there will still be virus circulating because none of the vaccines is 100 per cent effective against transmission."At the same time, ensuring the world is vaccinated will drastically reduce the severity of the disease and the need for treatment.
300,000 courses is likely more then 300,000 doses. 'Molnupiravir could be taken by people with mild or moderate COVID-19 as a five-day course'
SBS Secured, so they may or may not arrive in the distant future. ScottMorrisonMP haa gone from vaccine announcements to pill announcements. More hot air! auspol
This will stir up the ivermectin advocates. Good news though for the hesitant?
WJGunning 'secured access'? Where did I hear that before?
ketaminh great, that about covers Casey.
Is this for the Hillsong congregation? It won't go much further ScottyTheAnnouncer
Geezus christ here we fkn go again 🙄
300,000 for how many Australians!! Under-ordering again?
50% is not promising, it’s probability.
Interesting the patent for Molnupiravir indicates it is a broad-spectrum antiviral designed to assist in killing influenza. Influenza. INFLUENZA. Do you get it yet? Are you following?
Hallelujah! Australia is in the process of securing the access to access the secured path to securing access so access can be secured to secure access. Then the opportunity may arise to allow access to actually securing the pharmaceutical to coincide with net zero in 2050.
Geopolitics
Well done! Beat the virus.
One non peer reviewed study with 202 patients and we open the cheque book.
The vaccine failed
doesn’t seem like enough though?! always under delivering Scott Morrison and the Liberals Vote them Out
Merck expects to produce 10 million courses of treatment by the end of 2021, with more doses expected to be produced in 2022. We will not see any of these pills this year! GregHuntMP is singing to the crowd about something that isn't going to happen this month or this Year!
Oh god. I remember similar announcements about vaccines. Let's see what happens.
$50 that Craig Kelly and Co. Will still try and push ivermectin instead as a wonder drug